Annual Shareholders Equity
$203.23 M
-$84.03 M-29.25%
31 December 2023
Summary:
IGM Biosciences annual stockholders equity is currently $203.23 million, with the most recent change of -$84.03 million (-29.25%) on 31 December 2023. During the last 3 years, it has fallen by -$178.58 million (-46.77%). IGMS annual shareholders equity is now -46.77% below its all-time high of $381.81 million, reached on 31 December 2020.IGMS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$78.95 M
-$43.41 M-35.48%
30 September 2024
Summary:
IGM Biosciences quarterly stockholders equity is currently $78.95 million, with the most recent change of -$43.41 million (-35.48%) on 30 September 2024. Over the past year, it has dropped by -$174.91 million (-68.90%). IGMS quarterly shareholders equity is now -79.32% below its all-time high of $381.81 million, reached on 31 December 2020.IGMS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IGMS Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -29.3% | -68.9% |
3 y3 years | -46.8% | -72.4% |
5 y5 years | +408.7% | -69.0% |
IGMS Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -46.8% | at low | -79.0% | at low |
5 y | 5 years | -46.8% | +408.7% | -79.3% | at low |
alltime | all time | -46.8% | +408.7% | -79.3% | +219.9% |
IGM Biosciences Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $78.95 M(-35.5%) |
June 2024 | - | $122.36 M(-24.1%) |
Mar 2024 | - | $161.25 M(-20.7%) |
Dec 2023 | $203.23 M(-29.3%) | $203.23 M(-19.9%) |
Sept 2023 | - | $253.86 M(-1.8%) |
June 2023 | - | $258.61 M(+8.0%) |
Mar 2023 | - | $239.43 M(-16.7%) |
Dec 2022 | $287.26 M(+17.3%) | $287.26 M(-12.5%) |
Sept 2022 | - | $328.18 M(-12.6%) |
June 2022 | - | $375.41 M(+83.6%) |
Mar 2022 | - | $204.52 M(-16.5%) |
Dec 2021 | $244.91 M | $244.91 M(-14.2%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $285.58 M(-11.4%) |
June 2021 | - | $322.46 M(-9.3%) |
Mar 2021 | - | $355.61 M(-6.9%) |
Dec 2020 | $381.81 M(+58.9%) | $381.81 M(+102.9%) |
Sept 2020 | - | $188.18 M(-9.1%) |
June 2020 | - | $206.95 M(-7.6%) |
Mar 2020 | - | $224.01 M(-6.8%) |
Dec 2019 | $240.23 M(-464.9%) | $240.23 M(-5.7%) |
Sept 2019 | - | $254.62 M(+211.5%) |
June 2019 | - | $81.73 M(-224.2%) |
Dec 2018 | -$65.83 M(+62.5%) | -$65.83 M |
Dec 2017 | -$40.50 M | - |
FAQ
- What is IGM Biosciences annual stockholders equity?
- What is the all time high annual shareholders equity for IGM Biosciences?
- What is IGM Biosciences annual shareholders equity year-on-year change?
- What is IGM Biosciences quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for IGM Biosciences?
- What is IGM Biosciences quarterly shareholders equity year-on-year change?
What is IGM Biosciences annual stockholders equity?
The current annual shareholders equity of IGMS is $203.23 M
What is the all time high annual shareholders equity for IGM Biosciences?
IGM Biosciences all-time high annual stockholders equity is $381.81 M
What is IGM Biosciences annual shareholders equity year-on-year change?
Over the past year, IGMS annual stockholders equity has changed by -$84.03 M (-29.25%)
What is IGM Biosciences quarterly stockholders equity?
The current quarterly shareholders equity of IGMS is $78.95 M
What is the all time high quarterly shareholders equity for IGM Biosciences?
IGM Biosciences all-time high quarterly stockholders equity is $381.81 M
What is IGM Biosciences quarterly shareholders equity year-on-year change?
Over the past year, IGMS quarterly stockholders equity has changed by -$174.91 M (-68.90%)